Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Healthcare Biotechnology
Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and... see more

TSX:MSCL - Post Discussion

Satellos Bioscience Inc > Ranked #1
View:
Comment by trumpmaster on Mar 30, 2023 4:05pm
Good article.  Would be nice to see MSCL market cap in the 100's of millions like number 2 and 3 on the list.  That would make my day!!   :)
Comment by Flatlander05 on Mar 30, 2023 4:11pm
100%
Comment by nozzpack on May 23, 2023 1:41pm
This will be a 25 bagger if  that small molecule drug with the potential to regenerate functional muscle is successful as it will have many advantages and benefits for patients muscular dystrophies.  So far, experimental results are very promising worthy of its IDP rating. The ride upwards will be very rewarding..  
Comment by london6ers on Jul 25, 2023 12:53pm
I agree but lots of the muscle is filled by scar tissue. What does this do? Replace scar tissue with functioning muscle cells? That's crazy if true..
Comment by london6ers on Aug 01, 2023 4:29pm
Yes plus many other applications. 
Satellos Bioscience Inc